IRAK4-IN-4, extracted from patent CN107163044A, Compound15, is a novel and potent inhibitor of interleukin-1 receptor–associated kinase 4 (IRAK4) with an IC50 of 2.8 nM. IRAK4-IN-4 also inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM

纯度：≥98%

CAS：1850276-58-2